XML 40 R22.htm IDEA: XBRL DOCUMENT
v3.25.4

Condensed Financial Information (Parent Company Only) | 12 Months Ended
--- | ---
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract] |
Condensed Financial Information (Parent Company Only) | Condensed Financial Information (Parent Company Only) Certain subsidiaries are subject to state regulatory restrictions which set minimum capitalization requirements and require us to maintain certain deposits in the form of cash, certificates of deposit and Treasury bills as protection in the event of insolvency. Refer to Note 11 Regulatory Requirements and Restricted Funds for more information. Since the restricted net assets of our subsidiaries exceed 25% of our consolidated net assets, the accompanying condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule 1 of Regulation S-X. This information should be read in conjunction with our consolidated financial statements. Alignment Healthcare, Inc. (Parent Company Only) Condensed Balance Sheets
| December 31, 2025 |  | December 31, 2024
Assets |  |  |
Investment in subsidiary | $ | 520,283 |  |  | $ | 425,033 |
Total assets | $ | 520,283 |  |  | $ | 425,033 |
Liabilities and Stockholders' Equity |  |  |
Due to subsidiary | 16,061 |  |  | 1,762 |
Accrued expenses | 1,769 |  |  | 1,992 |
Long-term debt, net of debt issuance costs | 323,176 |  |  | 321,428 |
Total liabilities | $ | 341,006 |  |  | $ | 325,182 |
Commitments and Contingencies (Note 14) |  |  |
Stockholders' Equity: |  |  |
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2025 and 2024, respectively; no shares issued and outstanding as of December 31, 2025 and 2024 | — |  |  | — |
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 204,153,619 and 191,778,639 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 205 |  |  | 192 |
Additional paid-in-capital | 1,188,089 |  |  | 1,107,952 |
Accumulated deficit | (1,009,017) |  |  | (1,008,293) |
Total Alignment Healthcare, Inc. stockholders' equity | 179,277 |  |  | 99,851 |
Total liabilities and stockholders' equity | $ | 520,283 |  |  | $ | 425,033 |
Alignment Healthcare, Inc. (Parent Company Only) Condensed Statements of Operations
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Revenues: |  |  |  |  |
Total revenues | $ | — |  |  | $ | — |  |  | $ | — |
Expenses: |  |  |  |  |
Selling, general, and administrative expenses | 530 |  |  | 443 |  |  | 488 |
Total expenses | 530 |  |  | 443 |  |  | 488 |
Loss from operations | (530) |  |  | (443) |  |  | (488) |
Other expenses: |  |  |  |  |
Interest expense | 15,786 |  |  | 1,700 |  |  | — |
Total other expenses | 15,786 |  |  | 1,700 |  |  | — |
Loss before income taxes | (16,316) |  |  | (2,143) |  |  | (488) |
Provision for income taxes | 16 |  |  | — |  |  | — |
Net loss of Parent Company | (16,332) |  |  | (2,143) |  |  | (488) |
Subsidiary's Net income (loss) | 15,354 |  |  | (125,928) |  |  | (147,685) |
Net loss | (978) |  |  | (128,071) |  |  | (148,173) |
Less: Net loss attributable to noncontrolling interest | (254) |  |  | (36) |  |  | (156) |
Net loss attributable to Alignment Healthcare, Inc. | $ | (724) |  |  | $ | (128,035) |  |  | $ | (148,017) |
Alignment Healthcare, Inc. (Parent Company Only) Condensed Statements of Cash Flows
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Operating Activities: |  |  |  |  |
Net loss attributable to Alignment Healthcare, Inc. | $ | (724) |  |  | $ | (128,035) |  |  | $ | (148,017) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |
Equity in loss of subsidiary | (15,100) |  |  | 125,892 |  |  | 147,529 |
Amortization of debt issuance costs | 1,761 |  |  | 220 |  |  | — |
Due to subsidiary | 14,063 |  |  | 1,923 |  |  | 488 |
Net cash provided by operating activities | — |  |  | — |  |  | — |
Investing Activities: |  |  |  |  |
Investment in Subsidiary | (18,068) |  |  | (321,525) |  |  | — |
Net cash used in investing activities | (18,068) |  |  | (321,525) |  |  | — |
Financing Activities: |  |  |  |  |
Shares withheld net of restricted stock | — |  |  | (350) |  |  | — |
Stock options exercised | 18,068 |  |  | 155 |  |  | — |
Proceeds from long-term debt | — |  |  | 330,000 |  |  | — |
Debt issuance costs | — |  |  | (8,280) |  |  | — |
Net cash provided by financing activities | 18,068 |  |  | 321,525 |  |  | — |
Net (decrease) increase in cash | — |  |  | — |  |  | — |
Cash, cash equivalents and restricted cash at beginning of period | — |  |  | — |  |  | — |
Cash, cash equivalents and restricted cash at end of period | $ | — |  |  | $ | — |  |  | $ | — |
Supplemental non-cash financing and investing activities: |  |  |  |  |
Contribution of equity to subsidiary related to equity-based compensation | $ | 62,082 |  |  | $ | 71,132 |  |  | $ | 66,835 |
Debt issuance costs in accounts payable | $ | 26 |  |  | $ | 512 |  |  | $ | — |
Basis of Presentation Alignment Healthcare, Inc's. (the "Parent") parent company financial information has been derived from our consolidated financial statements and have been presented on a "parent-only" basis. Under a parent-only presentation, the investment in subsidiaries is presented under the equity method of accounting. The accounting policies for the parent company are the same as those described in Note 2 Summary of Significant Accounting Policies. The Parent is a holding company with no material operations of its own that conducts substantially all of its activities through its subsidiaries. The Parent has no cash and, as a result, expenses and obligations of the Parent are allocated to and paid by its subsidiaries. The accompanying condensed financial information of the Parent should be read in conjunction with the consolidated financial statements and accompanying notes. Investment in Subsidiary For purposes of these condensed financial statements, our wholly owned subsidiaries are recorded using the equity method of accounting. Investment in subsidiary represents capital contributions to subsidiaries and return of capital from our subsidiaries to us. The Parent and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Parent. Income taxes are allocated to each subsidiary in an amount equivalent to the amount which would be recognized by the subsidiary if it filed a separate tax return. Commitments and Contingencies Alignment Healthcare, Inc., along with certain other subsidiaries, is a guarantor of the Term Loans discussed in Note 8 Long-Term Debt. The Terms Loans were repaid in full in November 2024. For a summary of additional commitments and contingencies, see Note 14 Commitments and Contingencies. Long-Term Debt On November 22, 2024, Alignment Healthcare Inc. completed the sale of $330,000 of its 4.25% Convertible Senior Notes. See Note 8 Long-Term Debt for further discussion.

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration